Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Beats Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +62.96% and +6.94%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?